Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.32 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.27 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 85 | 0.85 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 1072
Sealed predictions
- DSTN in dopamine neurons, braak+0.23 (p 0.551) → +0.79 (p 0.011)receipt 1077
Swarm cases
receipt 1077: DSTN in dopamine neurons, braak
- power
- full sample +0.41 (p 0.089, n 18), 95% CI -0.07 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.48 (p 0.042, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.53 (p 0.023, n 18). not the mix.
- skeptic
- leave-one-out range +0.34 to +0.52, sign flips 0; without severely affected donors +0.41 (p 0.089, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DSTN in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts